Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study.
Shumilov E, Wurm-Kuczera R, Kerkhoff A, Wang M, Melchardt T, Holtick U, Bacher U, Staber PB, Mazzeo P, Leng C, Böckle D, Hölscher AS, Kauer J, Rotter N, Vucinic V, Rudzki JD, Nachbaur D, Bücklein VL, Schnetzke U, Krämer I, Wille K, Hasse A, von Tresckow B, Hänel M, Koenecke C, Velazquez GF, Viardot A, Schmid C, Thurner L, Wolf D, Subklewe M, Dreyling M, Dreger P, Dietrich S, Keller U, Jaeger U, Greil R, Pabst T, Lenz G, Chapuy B. Shumilov E, et al. Among authors: lenz g. Blood Adv. 2024 Dec 11:bloodadvances.2024014903. doi: 10.1182/bloodadvances.2024014903. Online ahead of print. Blood Adv. 2024. PMID: 39661985
Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial data.
Stelljes M, Sockel K, Floeth M, Schetelig J, Bornhäuser M, Reicherts C, Lenz G, Schroeder T, Markiewicz M, Labussiere-Wallet H, Reményi P, Ciceri F, Khan I, Pichlmeier U, Li X, Stölzel F. Stelljes M, et al. Among authors: lenz g. Bone Marrow Transplant. 2024 Nov 5. doi: 10.1038/s41409-024-02456-3. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39500997 No abstract available.
Megastudy testing 25 treatments to reduce antidemocratic attitudes and partisan animosity.
Voelkel JG, Stagnaro MN, Chu JY, Pink SL, Mernyk JS, Redekopp C, Ghezae I, Cashman M, Adjodah D, Allen LG, Allis LV, Baleria G, Ballantyne N, Van Bavel JJ, Blunden H, Braley A, Bryan CJ, Celniker JB, Cikara M, Clapper MV, Clayton K, Collins H, DeFilippis E, Dieffenbach M, Doell KC, Dorison C, Duong M, Felsman P, Fiorella M, Francis D, Franz M, Gallardo RA, Gifford S, Goya-Tocchetto D, Gray K, Green J, Greene J, Güngör M, Hall M, Hecht CA, Javeed A, Jost JT, Kay AC, Kay NR, Keating B, Kelly JM, Kirk JRG, Kopell M, Kteily N, Kubin E, Lees J, Lenz G, Levendusky M, Littman R, Luo K, Lyles A, Lyons B, Marsh W, Martherus J, Maurer LA, Mehl C, Minson J, Moore M, Moore-Berg SL, Pasek MH, Pentland A, Puryear C, Rahnama H, Rathje S, Rosato J, Saar-Tsechansky M, Almeida Santos L, Seifert CM, Shariff A, Simonsson O, Spitz Siddiqi S, Stone DF, Strand P, Tomz M, Yeager DS, Yoeli E, Zaki J, Druckman JN, Rand DG, Willer R. Voelkel JG, et al. Among authors: lenz g. Science. 2024 Oct 18;386(6719):eadh4764. doi: 10.1126/science.adh4764. Epub 2024 Oct 18. Science. 2024. PMID: 39418366
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.
Schoefbaenker M, Günther T, Lorentzen EU, Romberg ML, Hennies MT, Neddermeyer R, Müller MM, Mellmann A, Bojarzyn CR, Lenz G, Stelljes M, Hrincius ER, Vollenberg R, Ludwig S, Tepasse PR, Kühn JE. Schoefbaenker M, et al. Among authors: lenz g. PLoS Pathog. 2024 Oct 15;20(10):e1012624. doi: 10.1371/journal.ppat.1012624. eCollection 2024 Oct. PLoS Pathog. 2024. PMID: 39405332 Free PMC article.
Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials.
Lenz G, Tilly H, Ziepert M, Altmann B, Herbaux C, Frontzek F, Nickelsen M, Lee C, Hirata J, Sahin D, Chohan S, Batlevi CL, Yan M, Morschhauser F, Schmitz N. Lenz G, et al. Leukemia. 2024 Dec;38(12):2709-2711. doi: 10.1038/s41375-024-02420-6. Epub 2024 Sep 25. Leukemia. 2024. PMID: 39322715 Free PMC article. No abstract available.
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma.
Willis BS, Mongeon K, Dry H, Neveras IL, Bryan N, Pandya M, Roderick-Richardson J, Xu W, Yang L, Rosen A, Reimer C, Tuskova L, Klener P, Mettetal JT, Lenz G, Barry ST. Willis BS, et al. Among authors: lenz g. Leukemia. 2024 Dec;38(12):2663-2674. doi: 10.1038/s41375-024-02401-9. Epub 2024 Sep 16. Leukemia. 2024. PMID: 39284898 Free PMC article.
619 results